Testing effectiveness (Phase 2)Study completedNCT01351610
What this trial is testing
Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia
Who this might be right for
Critical Limb IschemiaPeripheral Artery Disease
Apceth GmbH & Co. KG 25